What's Next In: Packaging - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

What's Next In: Packaging

Pharmaceutical Technology

A frustrated baby boomer will invent a child-resistant cap that keeps toddlers out, yet allows adults easy access.

There was a time when the credo of the boomer generation was "Don't trust anyone over 30." Now long past 30, today's boomers still have an attitude about age. They're going to ignore it as long as possible. However, as boomers push 50 or 60 and begin taking more prescription drugs for chronic conditions and dietary to maintain or improve their health, it's only a matter of time before someone comes up with a concept that ends the struggle to open child-resistant containers.

Hallie Forcinio, contributing editor,
Pharmaceutical Technology

Industry experts give their predictions for the next 30 years. Read Editor-in-Chief Michelle Hoffman's introduction here. See what's next in:

Strategy and Regulation
Solid-Dosage Formulation
Drug Delivery
Analytical Testing
Information Technology


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here